Sweet Cherry Extract Targets the Hallmarks of Cancer in Prostate Cells: Diminished Viability, Increased Apoptosis and Suppressed Glycolytic Metabolism

References

• McCune LM, Kubota C, Stendell-Hollis NR, and Thomson CA: Cherries and health: a review. Crit Rev Food Sci Nutr 51, 1–12, 2011.
   PubMed Web of Science ®Google Scholar
• Gonçalves B, Landbo A-K, Knudsen D, Silva AP, Moutinho-Pereira J, et al. Effect of ripeness and postharvest storage on the phenolic profiles of cherries (Prunus avium L.). J Agric Food Chem 52, 523–530, 2004.
   PubMed Web of Science ®Google Scholar
• Serra AT, Duarte RO, Bronze MR, and Duarte CM: Identification of bioactive response in traditional cherries from Portugal. Food Chem 125, 318–325, 2011.
   Web of Science ®Google Scholar
• Rosado T, Henriques I, Gallardo E, and Duarte A: Determination of melatonin levels in different cherry cultivars by high-performance liquid chromatography coupled to electrochemical detection. Eur Food Res Technol 243, 1749–1757, 2017.
   Web of Science ®Google Scholar
• Huang W, Yan Z, Li D, Ma Y, Zhou J, et al. Antioxidant and anti-inflammatory effects of blueberry anthocyanins on high glucose-induced human retinal capillary endothelial cells. Oxid Med Cell Longev 2018, 1862462, 2018.
   PubMed Web of Science ®Google Scholar
• Li AN, Li S, Zhang YJ, Xu XR, Chen YM, et al. Resources and biological activities of natural polyphenols. Nutrients 6, 6020–6047, 2014.
   PubMed Web of Science ®Google Scholar
• Tsuda T, Horio F, and Osawa T: The role of anthocyanins as an antioxidant under oxidative stress in rats. Biofactors 13, 133–139, 2000.
   PubMed Web of Science ®Google Scholar
• Reddivari L, Vanamala J, Chintharlapalli S, Safe SH, and Miller JC, Jr.: Anthocyanin fraction from potato extracts is cytotoxic to prostate cancer cells through activation of caspase-dependent and caspase-independent pathways. Carcinogenesis 28, 2227–2235, 2007.
   PubMed Web of Science ®Google Scholar
• Kang S-Y, Seeram NP, Nair MG, and Bourquin LD: Tart cherry anthocyanins inhibit tumor development in ApcMin mice and reduce proliferation of human colon cancer cells. Cancer Lett 194, 13–19, 2003.
   PubMed Web of Science ®Google Scholar
• Ogur R, Istanbulluoglu H, Korkmaz A, Barla A, Faruk Tekbas O, et al. Report: investigation of anti-cancer effects of cherry in vitro. Pak J Pharm Sci 27, 587–592, 2014.
   PubMed Web of Science ®Google Scholar
• Malik A, Afaq F, Sarfaraz S, Adhami VM, Syed DN, et al. Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer. Proc Natl Acad Sci USA 102, 14813–14818, 2005.
   PubMed Web of Science ®Google Scholar
• Labrie F: Hormonal therapy of prostate cancer. In: Progress in Brain Research. Amsterdam, The Netherlands: Elsevier. 2010, pp. 321–341.
   Google Scholar
• Wadosky KM and Koochekpour S: Molecular mechanisms underlying resistance to androgen deprivation therapy in prostate cancer. Oncotarget 7, 64447–64470, 2016.
   PubMedGoogle Scholar
• Kelley DS, Adkins Y, and Laugero KD: A review of the health benefits of cherries. Nutrients 10, 368, 2018.
   PubMed Web of Science ®Google Scholar
• Leitzmann MF and Rohrmann S: Risk factors for the onset of prostatic cancer: age, location, and behavioral correlates. Clin Epidemiol 4, 1–11, 2012.
   PubMedGoogle Scholar
• Lin P-H, Aronson W, and Freedland SJ: Nutrition, dietary interventions and prostate cancer: the latest evidence. BMC Med 13, 3, 2015.
   PubMed Web of Science ®Google Scholar
• Labbé DP, Zadra G, Ebot EM, Mucci LA, Kantoff PW, et al. Role of diet in prostate cancer: the epigenetic link. Oncogene 34, 4683–4691, 2015.
   PubMed Web of Science ®Google Scholar
• Hanahan D and Weinberg RA: Hallmarks of cancer: the next generation. Cell 144, 646–674, 2011.
   PubMed Web of Science ®Google Scholar
• Massie CE, Lynch A, Ramos-Montoya A, Boren J, Stark R, et al. The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis. EMBO J 30, 2719–2733, 2011.
   PubMed Web of Science ®Google Scholar
• Vaz CV, Alves MG, Marques R, Moreira PI, Oliveira PF, et al. Androgen-responsive and nonresponsive prostate cancer cells present a distinct glycolytic metabolism profile. Int J Biochem Cell Biol 44, 2077–2084, 2012.
   PubMed Web of Science ®Google Scholar
• Vaz CV, Marques R, Alves MG, Oliveira PF, Cavaco JE, et al. Androgens enhance the glycolytic metabolism and lactate export in prostate cancer cells by modulating the expression of GLUT1, GLUT3, PFK, LDH and MCT4 genes. J Cancer Res Clin Oncol 142, 5–16, 2016.
   PubMed Web of Science ®Google Scholar
• Luis A, Neiva D, Pereira H, Gominho J, Domingues F, et al. Stumps of Eucalyptus globulus as a source of antioxidant and antimicrobial polyphenols. Molecules 19, 16428–16446, 2014.
   PubMed Web of Science ®Google Scholar
• Lee J, Durst RW, and Wrolstad RE: Determination of total monomeric anthocyanin pigment content of fruit juices, beverages, natural colorants, and wines by the pH differential method: collaborative study. J AOAC Int 88, 1269–1278, 2005.
   PubMed Web of Science ®Google Scholar
• Gonçalves J, Ramos R, Luís Â, Rocha S, Rosado T, et al. Assessment of the bioaccessibility and bioavailability of the phenolic compounds of Prunus avium L. by in vitro digestion and cell model. ACS Omega 4, 7605−7613, 2019.
   Web of Science ®Google Scholar
• Vander Heiden MG and DeBerardinis RJ: Understanding the Intersections between metabolism and cancer biology. Cell 168, 657–669, 2017.
   PubMed Web of Science ®Google Scholar
• Baltazar F, Pinheiro C, Morais-Santos F, Azevedo-Silva J, Queiros O, et al. Monocarboxylate transporters as targets and mediators in cancer therapy response. Histol Histopathol 29, 1511–1524, 2014.
   PubMed Web of Science ®Google Scholar
• Horoszewicz JS, Leong SS, Kawinski E, Karr JP, Rosenthal H, et al. LNCaP model of human prostatic carcinoma. Cancer Res 43, 1809–1818, 1983.
   PubMed Web of Science ®Google Scholar
• Horoszewicz J, Leong S, Chu TM, Wajsman Z, Friedman M, et al. The LNCaP cell line-a new model for studies on human prostatic carcinoma. Prog Clin Biol Res 37, 115–132, 1980.
   PubMedGoogle Scholar
• Kaighn ME, Narayan KS, Ohnuki Y, Lechner JF, and Jones LW: Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest Urol 17, 16–23, 1979.
   PubMedGoogle Scholar
• Gonçalves AC, Bento C, Silva BM, and Silva LR: Sweet cherries from Fundão possess antidiabetic potential and protect human erythrocytes against oxidative damage. Food Res Int 95, 91–100, 2017.
   PubMed Web of Science ®Google Scholar
• Porter AG and Jänicke RU: Emerging roles of caspase-3 in apoptosis. Cell Death Differ 6, 99, 1999.
   PubMed Web of Science ®Google Scholar
• Chappell WH, Lehmann BD, Terrian DM, Abrams SL, Steelman LS, and McCubrey JA: p53 expression controls prostate cancer sensitivity to chemotherapy and the MDM2 inhibitor Nutlin-3. Cell Cycle 11, 4579–4588, 2012.
   PubMed Web of Science ®Google Scholar
• Farnebo M, Bykov VJ, and Wiman KG: The p53 tumor suppressor: a master regulator of diverse cellular processes and therapeutic target in cancer. Biochem Biophys Res Commun 396, 85–89, 2010.
   PubMed Web of Science ®Google Scholar
• McEleny KR, Watson RW, Coffey RN, O'Neill AJ, and Fitzpatrick JM: Inhibitors of apoptosis proteins in prostate cancer cell lines. Prostate 51, 133–140, 2002.
   PubMed Web of Science ®Google Scholar
• Alcaraz A, Hammerer P, Tubaro A, Schröder FH, and Castro R: Is there evidence of a relationship between benign prostatic hyperplasia and prostate cancer? Findings of a literature review. Eur Urol 55, 864–873, 2009.
   PubMed Web of Science ®Google Scholar
• Halliwell B and Chirico S: Lipid peroxidation: its mechanism, measurement, and significance. Am J Clin Nutr 57, 715S–725S, 1993.
   PubMed Web of Science ®Google Scholar
• Klaunig JE, Kamendulis LM, and Hocevar BA: Oxidative stress and oxidative damage in carcinogenesis. Toxicol Pathol 38, 96–109, 2010.
   PubMed Web of Science ®Google Scholar
• Freitas M, Baldeiras I, Proença T, Alves V, Mota-Pinto A, and Sarmento-Ribeiro A: Oxidative stress adaptation in aggressive prostate cancer may be counteracted by the reduction of glutathione reductase. FEBS Open Bio 2, 119–128, 2012.
   PubMed Web of Science ®Google Scholar
• Pizzimenti S, Toaldo C, Pettazzoni P, Dianzani MU, and Barrera G: The “two-faced” effects of reactive oxygen species and the lipid peroxidation product 4-hydroxynonenal in the hallmarks of cancer. Cancers (Basel) 2, 338–363, 2010.
   PubMedGoogle Scholar
• Santos CR and Schulze A: Lipid metabolism in cancer. FEBS J 279, 2610–2623, 2012.
   PubMed Web of Science ®Google Scholar
• Barrera G: Oxidative stress and lipid peroxidation products in cancer progression and therapy. ISRN Oncol 2012, 137289, 2012.
   PubMedGoogle Scholar
• Van der Werf R, Walter C, Bietiger W, Seyfritz E, Mura C, et al. Beneficial effects of cherry consumption as a dietary intervention for metabolic, hepatic and vascular complications in type 2 diabetic rats. Cardiovasc Diabetol 17, 104, 2018.
   PubMed Web of Science ®Google Scholar
• Howatson G, McHugh MP, Hill JA, Brouner J, Jewell AP, et al. Influence of tart cherry juice on indices of recovery following marathon running. Scand J Med Sci Sports 20, 843–852, 2010.
   PubMed Web of Science ®Google Scholar
• Sozański T, Kucharska AZ, Dzimira S, Magdalan J, Szumny D, et al. Loganic acid and anthocyanins from cornelian cherry (Cornus mas L.) fruits modulate diet-induced atherosclerosis and redox status in rabbits. Adv Clin Exp Med 27, 1505–1513, 2018.
   PubMed Web of Science ®Google Scholar
• Wu T, Yin J, Zhang G, Long H, and Zheng X: Mulberry and cherry anthocyanin consumption prevents oxidative stress and inflammation in diet-induced obese mice. Mol Nutr Food Res 60, 687–694, 2016.
   PubMed Web of Science ®Google Scholar
• Li C, Zhang G, Zhao L, Ma Z, and Chen H: Metabolic reprogramming in cancer cells: glycolysis, glutaminolysis, and Bcl-2 proteins as novel therapeutic targets for cancer. World J Surg Onc 14, 15, 2015.
   Web of Science ®Google Scholar
• López-Lázaro M: The Warburg effect: why and how do cancer cells activate glycolysis in the presence of oxygen? Anticancer Agents Med Chem 8, 305–312, 2008.
   PubMed Web of Science ®Google Scholar
• Choi SYC, Collins CC, Gout PW, and Wang Y: Cancer‐generated lactic acid: a regulatory, immunosuppressive metabolite? J Pathol 230, 350–355, 2013.
   PubMed Web of Science ®Google Scholar
• Pertega-Gomes N, Vizcaino JR, Miranda-Goncalves V, Pinheiro C, Silva J, et al. Monocarboxylate transporter 4 (MCT4) and CD147 overexpression is associated with poor prognosis in prostate cancer. BMC Cancer 11, 312, 2011.
   PubMed Web of Science ®Google Scholar
• Doherty JR and Cleveland JL: Targeting lactate metabolism for cancer therapeutics. J Clin Invest 123, 3685–3692, 2013.
   PubMed Web of Science ®Google Scholar
• Greenlee H: Natural products for cancer prevention. Semin Oncol Nurs 28, 29–44, 2012.
   PubMedGoogle Scholar
• Gaziano JM, Sesso HD, Christen WG, Bubes V, Smith JP, et al. Multivitamins in the prevention of cancer in men: the Physicians' Health Study II randomized controlled trial. JAMA 308, 1871–1880, 2012.
   PubMed Web of Science ®Google Scholar
• Kamiloglu S, Capanoglu E, Grootaert C, and Van Camp J: Anthocyanin absorption and metabolism by human intestinal caco-2 cells–a review. IJMS 16, 21555–21574, 2015.
   Google Scholar
• Yan F, Zhang J, Zhang L, and Zheng X: Mulberry anthocyanin extract regulates glucose metabolism by promotion of glycogen synthesis and reduction of gluconeogenesis in human HepG2 cells. Food Funct 7, 425–433, 2016.
   PubMed Web of Science ®Google Scholar
• Huang B, Wang Z, Park JH, Ryu OH, Choi MK, et al. Anti-diabetic effect of purple corn extract on C57BL/KsJ db/db mice. Nutr Res Pract 9, 22–29, 2015.
   PubMed Web of Science ®Google Scholar
• Sasaki R, Nishimura N, Hoshino H, Isa Y, Kadowaki M, et al. Cyanidin 3-glucoside ameliorates hyperglycemia and insulin sensitivity due to downregulation of retinol binding protein 4 expression in diabetic mice. Biochem Pharmacol 74, 1619–1627, 2007.
   PubMed Web of Science ®Google Scholar
• Alzaid F, Cheung H-M, Preedy VR, and Sharp PA: Regulation of glucose transporter expression in human intestinal Caco-2 cells following exposure to an anthocyanin-rich berry extract. PLoS One 8, e78932, 2013.
   PubMed Web of Science ®Google Scholar
• Chandler JD, Williams ED, Slavin JL, Best JD, and Rogers S: Expression and localization of GLUT1 and GLUT12 in prostate carcinoma. Cancer 97, 2035–2042, 2003.
   PubMed Web of Science ®Google Scholar
• Pujol-Gimenez J, de Heredia FPr, Idoate MA, Airley R, Lostao MP, et al. Could GLUT12 be a potential therapeutic target in cancer treatment? A preliminary report. J Cancer 6, 139–143, 2015.
   PubMed Web of Science ®Google Scholar
• Pujol-Giménez J, Barrenetxe J, González-Muniesa P, and Lostao MP: The facilitative glucose transporter GLUT12: what do we know and what would we like to know? J Physiol Biochem 69, 325–333, 2013.
   PubMed Web of Science ®Google Scholar
• Cardoso HJ, Vaz CV, Correia S, Figueira MI, Marques R, et al. Paradoxical and contradictory effects of imatinib in two cell line models of hormone-refractory prostate cancer. Prostate 75, 923–935, 2015.
   PubMed Web of Science ®Google Scholar
• Yu M, Wang J, Muller DJ, and Helenius J: In PC3 prostate cancer cells ephrin receptors crosstalk to β 1-integrins to strengthen adhesion to collagen type I. Sci Rep 5, 8206, 2015.
   PubMed Web of Science ®Google Scholar
• Virtakoivu R, Pellinen T, Rantala JK, Perälä M, and Ivaska J: Distinct roles of AKT isoforms in regulating β1-integrin activity, migration, and invasion in prostate cancer. MBoC 23, 3357–3369, 2012.
   Google Scholar